XML 44 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statement of Cash Flows (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 28, 2013
Dec. 29, 2012
Dec. 31, 2011
Operating Activities      
Net Income Attributable to Kadant $ 23,419 $ 31,623 $ 33,575
Net income attributable to noncontrolling interest 229 198 274
Loss (Income) from discontinued operation 62 (743) 9
Income from continuing operations 23,710 31,078 33,858
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:      
Depreciation and amortization 9,775 8,384 7,936
Stock-based compensation expense 5,216 4,766 3,934
Gain on sale of property, plant and equipment (2,012) (214) (2,294)
Provision (Benefit) for losses on accounts receivable 374 (14) 1,249
Deferred income tax benefit (1,061) (4,868) (1,886)
Other items, net 1,485 1,107 (809)
Contributions to pension plan (1,080) (960) (900)
Changes in current assets and liabilities, net of effects of acquisitions:      
Accounts receivable (2,197) 1,157 (9,909)
Unbilled contract costs and fees (840) 236 (1,753)
Inventories (2,005) 9,156 (6,966)
Other current assets 113 (696) (1,897)
Accounts payable 2,552 (5,868) 4,469
Other current liabilities 5,905 (12,808) 9,330
Net cash provided by continuing operations 39,935 30,456 34,362
Net cash provided by (used in) discontinued operation 141 (1,348) (47)
Net cash provided by operating activities 40,076 29,108 34,315
Investing Activities      
Acquisitions, net of cash acquired (65,594) 85 (15,694)
Purchases of property, plant, and equipment (6,261) (4,250) (8,030)
Proceeds from sale of property, plant, and equipment 3,459 803 2,360
Dividend paid to noncontrolling interest (731) 0 (579)
Other, net 971 (3) 58
Net cash used in continuing operations for investing activities (68,156) (3,365) (21,885)
Financing Activities      
Proceeds from issuance of long-term obligations 53,609 5,000 5,000
Repayments of short- and long-term obligations (21,849) (10,375) (16,017)
Purchases of Company common stock (5,367) (14,491) (16,088)
Dividends paid (4,189) 0 0
Change in restricted cash (168) 700 (700)
Payment of debt issuance costs (154) (644) 0
Proceeds from issuance of Company common stock 337 358 390
Excess tax benefits from stock-based compensation awards 351 132 371
Net cash provided by (used in) continuing operations for financing activities 22,570 (19,320) (27,044)
Exchange Rate Effect on Cash from Continuing Operations 989 1,180 (241)
(Decrease) Increase in Cash and Cash Equivalents from Continuing Operations (4,521) 7,603 (14,855)
Cash and Cash Equivalents at Beginning of Year 54,553 46,950 61,805
Cash and Cash Equivalents at End of Year $ 50,032 $ 54,553 $ 46,950